Skip to content

Homoeopathic treatment of pain in limbs in diabetic patients

Individualized homoeopathic medicines as adjunctive to standard care for improving symptoms of peripheral diabetic neuropathy in middle-aged individuals: double-blind, randomized, placebo-controlled trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050267
Enrollment
136
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Intervention1: Individualized homeopathic medicines plus standard antidiabetic care: Intervention is planned as administering the indicated homeopathic medicines in centesimal potencies (cH), once or
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

D.N.De Homoeopathic Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients suffering from diabetic neuropathy for 3 months or more diagnosis confirmed by DNE > 3 clinical assessment. 2.Age between 30 and 65 years 3.Participants of either sex 4.Literate patients; ability to read English and/or Bengali, Hindi. 5.Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires. 6.Providing written informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Persons suffering from any other neurological disorders 2. DNE score 3 or less 3. Diabetic polyradiculopathy, diabetic amyotrophy, abnormality of gait, loss of arch with multiple fractures in tarsal bones wrist, foot drop. 4. Paralysis of III, IV, VI cranial nerve. 5. Neuropathy due to vitamin B12 deficiency to be determined by peripheral blood smear 6. Development of typical Charcot joints, particularly in the feet. 7. Complication of Diabetes (retinopathy, renal involvement or with history of recurrent acute complaints like hypoglycemia, keto-acidosis). 8. Immune-compromised patients. 9. Person taking homoeopathic medicine for any other cause 10. Vulnerable population - unconscious, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people 11. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. 12. Pregnant and puerperal women, lactating mothers 13. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 14. Self-reported immune-compromised state 15. Already undergoing homoeopathic treatment for chronic disease within last 6 months 16. Simultaneous participation in any other clinical trials 17. Persons dependent on insulin or requiring insulin as per guideline of the Director of West Bengal Health Service whose HBA1C 10 or above

Design outcomes

Primary

MeasureTime frame
Neuropathic total symptom score 6 (NTSS-6)Timepoint: At the baseline, and every month, up to 3 months

Secondary

MeasureTime frame
Diabetic neuropathic examination (DNE) scoreTimepoint: At the baseline, and every month, up to 3 months;DN4 questionnairesTimepoint: At the baseline, and every month, up to 3 months;HbA1C%Timepoint: At the baseline and after 3 months;McGill pain short form questionnaireTimepoint: At the baseline, and every month, up to 3 months

Countries

India

Contacts

Public ContactShubhamoy Ghosh

D. N. De Homoeopathic Medical College and Hospital

shubhamoy67@gmail.com8240327883

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026